Correction to ‘The early injected genomic region determines sensitivity to Type I restriction-modification defence against Autographiviridae phages ’

Key Points

• Sensitivity to Type I restriction-modification defence is determined by the genomic region injected early during infection.
• The correction highlights the specific genomic region's role, impacting how phages interact with their host.
• Observational analysis highlights the implications of genomic characteristics on phage susceptibility and defence.
• This finding supports further exploration of genomic influences on viral resistance and phage therapy interventions.